Alfa Wassermann has named Mark Flocco and Dino DiCamillo as vice president and president, respectively, to its proteomic technologies division, Alfa Wassermann Proteomic Technologies.
DiCamillo comes to Alfa Wassermann from Invitrogen, where he was vice president of environmental diagnostics and commercial operations. Prior to that, he was president of Dynal Biotech, spent 13 years with Applied Biosystems, and has worked for Nicolet Instruments and Bio-Rad Laboratories.
DiCamillo is a graduate of Lake Superior State University and earned an executive MBA from Temple University.
Flocco was appointed to the newly created position of vice president of business development and marketing. He most recently served as business development manager for clinical proteomics and biomarker discovery at Bruker Daltonics before joining Alfa Wassermann. Previously, Flocco worked as the northeast regional sales manager for Ciphergen Biosystems. He worked for eight years at Beckman Coulter in sales, marketing, and technical roles, and also served as director of microchemistry at Princeton University.
Flocco earned a BS in biology at Widener College.
HTG added two new national account managers to its sales force to meet increased demand for its ArrayPlate qNPA technology in two US regions, the company said last week.
Craig Rine and Michael Angarita will be responsible for sales and support of HTG's quantitative Nuclease Protection Assay technology in the Northeast and Midwest, respectively.
Rine joins the company after serving as drug discovery manager of Invitrogen. He also served as the director of US sales at MesoScale Discovery and director of the academic market segment at PerkinElmer Life Sciences. Angarita comes to HTG from Telechem International, where he was director of sales.